Nov 30, 2023
ORBITA-2 was designed to test whether stents reduce angina more than a placebo procedure in patients with single or multivessel disease on little or no antianginal medication at 12 weeks of follow up.
In this interview, Christopher Rajkumar, MD, Rasha Al-Lamee, MD, and William E. Boden MD, FACC, discuss AHA...
Nov 28, 2023
Nonischemic cardiomyopathy (NICM) is common and patients are at significant risk for early mortality secondary to ventricular arrhythmias.
In this interview, Jonathan Chrispin MD, FACC, and Dhanunjaya “DJ” Lakkireddy MBBS, FACC, discuss Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy.
Nov 21, 2023
Detecting HF (cardiac dysfunction) during pregnancy and shortly after having a baby can be challenging for health care professionals and is often delayed. The use of a device powered by artificial intelligence can assist health care providers in identifying this condition earlier.
In this interview, Demilade A.
Nov 17, 2023
Results of this trial indicate that dapagliflozin treatment immediately after an acute heart attack reduced adverse cardiovascular and metabolic outcomes. In this interview, Stefan James MD, PhD and Laxmi Mehta MD, FACC, discuss AHA Late-Breaker: DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients...
Nov 7, 2023
Testosterone is widely prescribed to aging men but there have been concerns about heart-related safety. The FDA mandated that the makers of testosterone products conduct a trial to determine if these drugs increase the risk of heart attack or stroke.
In this interview, Steven E. Nissen, MD, MACC, and William...